Positron Opens Pharmaceutical Facility in Indiana
08/10/2010
"While the company's plan is to focus on small batch, radioactive PET products, the facility will also be utilized to support current and future Positron equipment, as well as, expand into new markets," said John Zehner, Positron COO.
The approximately 10,000-square-foot facility has room for the company to expand, and includes a clean room and laboratory to produce pharmaceuticals for industrial and medical applications. All products made at the Indiana facility will meet or exceed Food and Drug Administration (FDA) requirements.
Most Read
-
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019
-
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Q3 2019
-
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
Q3 2020
-
A Heightened Focus on Reshoring
Q3 2020
-
How are Uncertain Times Altering Company Location Strategies?
Q3 2020
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020